IMC is the medical partner for City Walk - ZAWYA
| 5116 Stock | 1.39 0.01 0.72% |
About 51% of Al Aqar's investor base is interested to short. The analysis of current outlook of investing in Al Aqar Healthcare suggests that many traders are impartial regarding Al Aqar's prospects. Al Aqar's investing sentiment shows overall attitude of investors towards Al Aqar Healthcare.
Al Aqar stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of 5116 daily returns and investor perception about the current price of Al Aqar Healthcare as well as its diversification or hedging effects on your existing portfolios.
5116 |
IMC is the medical partner for City Walk ZAWYA
Read at news.google.com
 |
Al Aqar Fundamental Analysis
We analyze Al Aqar's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Al Aqar using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Al Aqar based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
Al Aqar is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Al Aqar Healthcare Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Al Aqar stock to make a market-neutral strategy. Peer analysis of Al Aqar could also be used in its relative valuation, which is a method of valuing Al Aqar by comparing valuation metrics with similar companies.
Peers
Al Aqar Related Equities
| 4324 | Hengyuan Refining | 0.98 | ||||
| 0097 | ViTrox Bhd | 0.30 | ||||
| 0148 | Sunzen Biotech | 3.13 | ||||
| 7243 | Impiana Hotels | 4.55 | ||||
| 7219 | Minetech Resources | 7.14 |
Other Information on Investing in 5116 Stock
Al Aqar financial ratios help investors to determine whether 5116 Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 5116 with respect to the benefits of owning Al Aqar security.